Convertible Notes Modification and Default Waiver AgreementConvertible Notes Modification and Default Waiver Agreement • January 27th, 2023 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 27th, 2023 Company Industry JurisdictionThis Convertible Notes Modification and Default Waiver Agreement (the "Agreement") is entered into as of January 23, 2023 (the "Effective Date") by and between TL-66 LLC, a California limited liability company ("Creditor") and Axim Biotechnologies, Inc., a Nevada corporation ("AXIM" or the "Company") and Sapphire Biotechnologies, Inc, a Delaware corporation, wholly owned subsidiary of AXIM ("Sapphire"), with reference to the following facts.